Jonathan Jay Mazelsky, President & CEO at IDEXX LABORATORIES INC /DE (IDXX), sold 9,305 shares at $465.02 ($4.1M) on 2020-11-05, disclosed to the SEC on 2020-11-09.
Open-market sale of $4.1M IDXX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 600 | $0 | 0.0% |
| 2 | $463.45 | 355 | $165K | 4.0% |
| 3 | $463.45 | 355 | $165K | 4.0% |
| 4 | $465.02 | 1,307 | $608K | 14.9% |
| 5 | $465.02 | 1,307 | $608K | 14.9% |
| 6 | $465.81 | 107 |
| $50K |
| 1.2% |
| 7 | $467.33 | 310 | $145K | 3.6% |
| 8 | $467.33 | 310 | $145K | 3.6% |
| 9 | $468.47 | 209 | $98K | 2.4% |
| 10 | $468.47 | 209 | $98K | 2.4% |
| 11 | $468.92 | 400 | $188K | 4.6% |
| 12 | $469.86 | 246 | $116K | 2.8% |
| 13 | $469.86 | 246 | $116K | 2.8% |
| 14 | $470.34 | 714 | $336K | 8.2% |
| 15 | $470.34 | 714 | $336K | 8.2% |
| 16 | $470.79 | 100 | $47K | 1.2% |
| 17 | $471.34 | 264 | $124K | 3.1% |
| 18 | $471.34 | 264 | $124K | 3.1% |
| 19 | $473.99 | 147 | $70K | 1.7% |
| 20 | $473.99 | 147 | $70K | 1.7% |
| 21 | $473.99 | 247 | $117K | 2.9% |
| 22 | $473.99 | 247 | $117K | 2.9% |
| 23 | $475.18 | 200 | $95K | 2.3% |
| 24 | $476.73 | 300 | $143K | 3.5% |
| Total | $438.25 avg | 9,305 | $4.1M | 100% |
| Filing → |
| IDXX | SELL | 2024-02-09 | $13.7M | — | Filing → |
| IDXX | SELL | 2023-12-06 | $7.3M | — | Filing → |
| IDXX | SELL | 2023-09-05 | $13.7M | — | Filing → |